Loading...
Acutus Medical, Inc.
AFIB•NASDAQ
Healthcare
Medical - Devices
$0.002
$-0.00(-33.33%)
Acutus Medical, Inc. (AFIB) Financial Performance & Statements
Review Acutus Medical, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
181.37%
↑ 181.37%
Operating Income Growth
99.60%
↑ 99.60%
Net Income Growth
88.31%
↑ 88.31%
Operating Cash Flow Growth
49.84%
↑ 49.84%
Operating Margin
-0.28%
↓ 0.28%
Gross Margin
5.03%
↑ 5.03%
Net Profit Margin
-47.36%
↓ 47.36%
ROE
124.33%
↑ 124.33%
ROIC
-0.35%
↓ 0.35%
Acutus Medical, Inc. (AFIB) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Acutus Medical, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $7.14M | $5.27M | $4.13M | $3.63M |
| Cost of Revenue | $6.13M | $4.89M | $4.47M | $3.65M |
| Gross Profit | $1.01M | $372000.00 | -$343000.00 | -$30000.00 |
| Gross Profit Ratio | $0.14 | $0.07 | -$0.08 | -$0.008 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.56M | $2.32M | $2.23M | $3.34M |
| Operating Expenses | -$1.51M | -$117000.00 | -$644000.00 | $3.34M |
| Total Costs & Expenses | $1.75M | $4.78M | $6.70M | $6.99M |
| Interest Income | $122000.00 | $153000.00 | $207000.00 | $281000.00 |
| Interest Expense | $1.38M | $1.40M | $1.51M | $1.48M |
| Depreciation & Amortization | $250000.00 | $257000.00 | $256000.00 | $264000.00 |
| EBITDA | $322000.00 | $836000.00 | $1.40M | -$313000.00 |
| EBITDA Ratio | $0.05 | $0.16 | $0.34 | -$0.09 |
| Operating Income | -$272000.00 | $489000.00 | $301000.00 | -$575000.00 |
| Operating Income Ratio | -$0.04 | $0.09 | $0.07 | -$0.16 |
| Other Income/Expenses (Net) | -$1.03M | -$1.30M | -$663000.00 | -$1.48M |
| Income Before Tax | -$1.30M | -$816000.00 | -$362000.00 | -$2.06M |
| Income Before Tax Ratio | -$0.18 | -$0.15 | -$0.09 | -$0.57 |
| Income Tax Expense | -$4.78M | $4.79M | $0.00 | -$10000.00 |
| Net Income | -$1.41M | -$5.61M | -$914000.00 | -$1.62M |
| Net Income Ratio | -$0.20 | -$1.06 | -$0.22 | -$0.45 |
| EPS | -$0.04 | -$0.19 | -$0.03 | -$0.05 |
| Diluted EPS | -$0.04 | -$0.19 | -$0.03 | -$0.05 |
| Weighted Avg Shares Outstanding | $29.77M | $29.80M | $29.72M | $29.69M |
| Weighted Avg Shares Outstanding (Diluted) | $29.77M | $29.80M | $29.72M | $29.69M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan